Columbia Care Secures Over CA$25M in Funding Via Another Deal With Canaccord

Columbia Care Inc. CCHW CCHWF is poised to raise some CA$25.2 million ($19.8 million) in funding via a bought deal private placement deal.

Under the agreement, the New York cannabis company agreed to sell some 2.8 million of its common shares to Canaccord Genuity Corp. at CA$9 ($7.1) per share.

Columbia Care noted it expects the offering to be mainly sold to one institutional investor.

According to a Tuesday press release, Canaccord Genuity agreed to purchase the shares for resale.

The company also said it anticipates finalizing the deal on or about Feb. 25, or once it receives all regulatory approvals.

Canaccord Genuity was given an option to buy up to an additional number of shares matching 15% of the number of shares that were initially sold under the offering.

This is yet another deal where Columbia Care has teamed up with Canaccord in recent months.

In January, Columbia Care disclosed its plans to secure up to CA$130 million ($102.5 million) via a bought deal offering.

Under the agreement with Canaccord, the company opted to sell some 16.1 million of its common shares to a syndicate of underwriters at CA$8.05 per share.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: CannabisNewsEurozoneFinancingOfferingsSmall CapMarketsGeneralCanaccord Genuity Corp.Cannabis CompanyColumbia Care Inc.DealInstitutional InvestorPrivate PlacementPurchaseSharesstocks
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis is evolving – don’t get left behind!

Curious about what’s next for the industry and how to leverage California’s unique market?

Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!

Get your tickets now to secure your spot and avoid last-minute price hikes.